Healthcare -
Biotechnology - NASDAQ - US
$ 0.3559
0.993 %
$ 4.01 M
Market Cap
-0.01
P/E
CYCC - OPERATING INCOME
Operating Income CYCC - Cyclacel Pharmaceuticals, Inc.
-25.5 M
LAST VALUE
-5.34%
2 YEAR CAGR
-21.66%
5 YEAR CAGR
-3.54%
10 YEAR CAGR